Ken Harewood | |
---|---|
Born | Barbados |
Occupation | scientist |
Education | Lodge School, Barbados, New York University, City College of the City University of New York, New York Blood Center |
Ken Harewood is a molecular biologist with a history of contributions to biomedical research. [1] [2] [3]
Ken Harewood was formerly GlaxoSmithKline Distinguished Professor and Director of the North Carolina Central University (NCCU) Julius L. Chambers Biomedical/Biotechnology Research institute [4] [5] and is recognized for his work in the fields of cancer biology and cancer drug discovery. In 2008 he was appointed by Gov. Mike Easley to the N.C. Board of Science and Technology and served on the N.C. Biotechnology Center board of directors [6] and is a member of the UNC Tomorrow Scholars' Council. Harewood has also served as Adjunct professor in the Department of Molecular Genetics and Microbiology at Duke University.
Harewood is a native of Barbados and received his secondary education there at the Lodge School. As a secondary student he excelled at soccer and became team captain of the Barbados National Soccer Team. Harewood came to the United States as an undergraduate to study biology at New York University. He then did graduate work at the City College of the City University of New York, where he earned his Master's and Doctoral degrees in Biochemistry. He next did post-doctoral research at the New York Blood Center. [7]
After his training, Harewood accepted a laboratory position with Pfizer at its cancer research center in Maywood, New Jersey, [8] later moving to Pfizer Central Research in Groton, Connecticut, where he rose to the position of Project Leader and Principal Research Investigator in the Department of Molecular genetics. He and his team at Pfizer were the first to clone the gene for bovine calf rennin, leading to commercialization of the first food processing enzyme made using recombinant DNA technology. [7] Harewood also contributed to discovery of the first human leukemia virus and HIV.[ citation needed ] His work on cancer resulted in novel cell-based methods for discovery of anti-cancer drugs. [7]
Harewood has received a number of honors and awards, including: the Harlem YMCA Black Achievers in Industry Award, the National Consortium for Black Professional Development Health Sciences Award, the 1998 Barbados Charity Fund Pride and Industry Award, the 2006 North Carolina Central University Chancellor's Merit Award, the 2006 University of North Carolina Oliver Max Gardner Award; [7] and the Barbados Barbados Gold Crown of Merit. [9]
Harewood is author of Beyond My Wildest Dreams (Lulu.com, 2012, 350 pp.) and The Biotech Revolution: Impact on Science Education in America (Authorhouse, 2020, 112 pp.). Based on his experience with rennin Harewood co-authored an article for high school teachers describing lab exercises using this enzyme. [10] [7]
Susan Lee Lindquist, ForMemRS was an American professor of biology at MIT specializing in molecular biology, particularly the protein folding problem within a family of molecules known as heat-shock proteins, and prions. Lindquist was a member and former director of the Whitehead Institute and was awarded the National Medal of Science in 2010.
David Baltimore is an American biologist, university administrator, and 1975 Nobel laureate in Physiology or Medicine. He is President Emeritus and Distinguished Professor of Biology at the California Institute of Technology (Caltech), where he served as president from 1997 to 2006. He also served as the director of the Joint Center for Translational Medicine, which joined Caltech and UCLA in a program to translate basic scientific discoveries into clinical realities. He also formerly served as president of Rockefeller University from 1990 to 1991, founder and director of the Whitehead Institute of Biomedical Research from 1982 to 1990, and was president of the American Association for the Advancement of Science in 2007.
Professor Michael H. Gelb is an American biochemist and chemist specializing in enzymes and particularly those of medical significance. He is the Boris and Barbara L. Weinstein Endowed Chair in Chemistry at the University of Washington in Seattle. He also teaches Honors Organic Chemistry, Chemical Biology and Enzymology.
Thomas Eugene Shenk is an American virologist. He is currently Emeritus Professor of Life Sciences in the Department of Molecular Biology at Princeton University.
The history of model organisms began with the idea that certain organisms can be studied and used to gain knowledge of other organisms or as a control (ideal) for other organisms of the same species. Model organisms offer standards that serve as the authorized basis for comparison of other organisms. Model organisms are made standard by limiting genetic variance, creating, hopefully, this broad applicability to other organisms.
Charles Thomas Caskey, also known as C. Thomas Caskey, was an American internist who has been a medical Geneticist and biomedical researcher and entrepreneur. He was a Professor of Molecular and Human Genetics at Baylor College of Medicine, and served as editor of the Annual Review of Medicine from 2001 to 2019. He was a member of the editorial boards of the Proceedings of the National Academy of Sciences, Science, the Encyclopedia of Molecular Medicine and numerous other medical and scientific journals.
The Dr. Paul Janssen Award for Biomedical Research is given annually by Johnson & Johnson to honor the work of an active scientist in academia, industry or a scientific institute in the field of biomedical research. It was established in 2004 and perpetuates the memory of Paul Janssen, the founder of Janssen Pharmaceutica, a Johnson & Johnson subsidiary.
Robert Tjian is a Hong Kong-born American biochemist best known for his work on eukaryotic transcription. He is currently Professor of Biochemistry and Molecular Biology at the University of California, Berkeley and an Investigator of the Howard Hughes Medical Institute (HHMI). On April 1, 2009, Tjian became the President of HHMI. On August 4, 2015, he announced that he would step down as President at the end of 2016.
Giulio Superti-Furga is an Italian molecular and systems biologist based in Vienna, Austria. He is the Scientific Director of CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, and Professor of Medical Systems Biology at the Medical University of Vienna.
Utpal Banerjee is a distinguished professor of the department of molecular, cell and developmental biology at UCLA. He obtained his Bachelor of Science degree in chemistry from St. Stephen's College, Delhi University, India and obtained his Master of Science degree in physical chemistry from the Indian Institute of Technology, Kanpur, India. In 1984, he obtained a PhD in chemistry from the California Institute of Technology where he was also a postdoctoral Fellow in the laboratory of Seymour Benzer from 1984-1988.
Thomas J. Kelly is an American cancer researcher whose work focuses on the molecular mechanisms of DNA replication. Kelly is director of the Sloan-Kettering Institute, the basic research arm of the Memorial Sloan-Kettering Cancer Center. He holds the Center's Benno C. Schmidt Chair of Cancer Research.
Bruce William Stillman, AO, FAA, FRS is a biochemist and cancer researcher who has served as the Director of Cold Spring Harbor Laboratory (CSHL) since 1994 and President since 2003. He also served as the Director of its NCI-designated Cancer Center for 25 years from 1992 to 2016. During his leadership, CSHL has been ranked as the No. 1 institution in molecular biology and genetics research by Thomson Reuters. Stillman's research focuses on how chromosomes are duplicated in human cells and in yeast Saccharomyces cerevisiae; the mechanisms that ensure accurate inheritance of genetic material from one generation to the next; and how missteps in this process lead to cancer. For his accomplishments, Stillman has received numerous awards, including the Alfred P. Sloan, Jr. Prize in 2004 and the 2010 Louisa Gross Horwitz Prize, both of which he shared with Thomas J. Kelly of Memorial Sloan-Kettering Cancer Center, as well as the 2019 Canada Gairdner International Award for biomedical research, which he shared with John Diffley.
Latvian Biomedical Research and Study Centre (LBMC) is the scientific institute in molecular biology and biomedicine in Latvia. Since its establishment in 1993 it has evolved into a scientific centre performing basic as well as applied research in molecular genetics, vaccine development, genomics and proteomics, cancer biology, immunology, biotechnology, stem cell biology, structure biology and other scientific areas.
Zhijian "James" Chen is a Chinese-American biochemist and Professor in the Department of Molecular Biology at University of Texas Southwestern Medical Center. He is best known for his discovery of mechanisms by which nucleic acids trigger innate and autoimmune responses from the interior of a cell, work for which he received the 2019 Breakthrough Prize in Life Sciences.
Inder Mohan Verma is an Indian American molecular biologist, the former Cancer Society Professor of Molecular Biology in the Laboratory of Genetics at the Salk Institute for Biological Studies and the University of California, San Diego. He is recognized for seminal discoveries in the fields of cancer, immunology, and gene therapy.
Ekkehard Karl Friedrich Bautz is a molecular biologist and chair of the Institute of Molecular Genetics at the University of Heidelberg.
James Michael Berger is an American academic working as a professor of biophysics and biophysical chemistry at Johns Hopkins University School of Medicine, where he is also the co-director of the Cancer Chemical and Structural Biology Program at the Sidney Kimmel Comprehensive Cancer Center and the director of the Johns Hopkins Institute for Basic Biomedical Sciences. His main area of research is the functions of molecular cellular machinery.
Gregory L. Verdine is an American chemical biologist, biotech entrepreneur, venture capitalist and university professor. He is a founder of the field of chemical biology, which deals with the application of chemical techniques to biological systems. His work has focused on mechanisms of DNA repair and cell penetrability.
Michael C. Ostrowski is an American cancer biologist and geneticist currently is the WH Folk Endowed Professor at Hollings Cancer Center, Medical University of South Carolina and an Elected Fellow at the American Association for the Advancement of Science. His interests are cancer cells and genes.